Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis

scientific article

Th17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1005469821
P356DOI10.1186/S12879-015-0891-2
P932PMC publication ID4374583
P698PubMed publication ID25888308
P5875ResearchGate publication ID276916293

P50authorChantal P. Bleeker-RoversQ57693616
Bart Jan KullbergQ62560089
Frank van de VeerdonkQ92689750
Mihai NeteaQ24517868
Anna SimonQ37385431
P2093author name stringKatharina L Becker
Corine E Delsing
P2860cites workAspergillus fumigatus evades immune recognition during germination through loss of toll-like receptor-4-mediated signal transductionQ73646662
Pattern recognition receptors and their role in invasive aspergillosisQ85644534
Aspergillus osteomyelitis: review of 12 cases identified by the Prospective Antifungal Therapy Alliance registry.Q37403093
Skull-base osteomyelitis: fungal vs. bacterial infection.Q37729271
IL-22 in tissue-protective therapyQ38093227
Osteomyelitis caused by Aspergillus species: a review of 310 reported casesQ38168573
IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytesQ38329713
Malignant external otitis: insights into pathogenesis, clinical manifestations, diagnosis, and therapyQ39520538
Aspergillus fumigatus-induced IL-22 is not restricted to a specific Th cell subset and is dependent on complement receptor 3.Q44947091
Malignant external otitis and osteomyelitis of the base of the skull.Q50558722
Fungal colonization of the paranasal sinuses.Q51192611
GM-CSF increases cross-presentation and CD103 expression by mouse CD8⁺ spleen dendritic cells.Q53241637
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesQ24303817
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodelingQ24647357
Aspergillus fumigatus and aspergillosisQ29617908
Aspergillosis of bones and joints - a review from 2002 until today.Q30727401
GM-CSF-dependent, CD103+ dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization.Q33839932
STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasisQ34196284
Steady-state and inflammatory dendritic-cell developmentQ34591334
Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case seriesQ35131761
Th1 and Th2 cytokines in mice with invasive aspergillosis.Q35567104
Emerging new drugs for wound repairQ36407396
Otogenic skull base osteomyelitis caused by invasive fungal infection. Case report and literature review.Q36560338
Infections in diabetes mellitus and hyperglycemia.Q36934696
The role of sargramostim (rhGM-CSF) as immunotherapyQ37015071
Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteriaQ37164085
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectosteomyelitisQ938983
base of skullQ1423729
P304page(s)140
P577publication date2015-03-21
P1433published inBMC Infectious DiseasesQ15759919
P1476titleTh17 cytokine deficiency in patients with Aspergillus skull base osteomyelitis
P478volume15

Reverse relations

cites work (P2860)
Q49188733Adaptive Immunity to Cryptococcus neoformans Infections
Q91159420Aspergillus Osteomyelitis of Clivus
Q89612940Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review
Q38803776In-host adaptation and acquired triazole resistance in Aspergillus fumigatus: a dilemma for clinical management
Q40101155The IDO-AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection
Q48163082The Multifaceted Role of T-Helper Responses in Host Defense against Aspergillus fumigatus

Search more.